14 Jun

What Could Limit Kimberly-Clark’s Sales


Sales headwinds

Kimberly-Clark (KMB) has beaten Wall Street’s sales estimates in the past three quarters. Its price restructuring initiatives and favorable mix have supported its organic sales growth, and in turn, its total revenue. Despite beating analysts’ estimates, Kimberly-Clark’s top line has fallen by a low-single-digit percentage YoY (year-over-year) in the past three quarters, due to currency volatility and weak volumes.

What Could Limit Kimberly-Clark’s Sales

Weak pricing in developed markets outside the US and lower volumes in developing and emerging markets have hurt its top line. Heightened competition in the value segment and low birth rates have also dragged it down.

We expect Kimberly-Clark’s top line to stay low in the second quarter of 2019, though its rate of decline could moderate. Higher pricing and an improved mix could support sales, while low volumes and currency rates could limit them.

We expect currency volatility and heightened competition to also impact sales for Procter & Gamble (PG) and Colgate-Palmolive (CL). However, pricing, innovation, and brand marketing could support them.

What does Wall Street expect?

Analysts expect Kimberly-Clark’s top line to stay muted in the coming quarters, with its net sales falling by a low-single-digit percentage in the second quarter and the fiscal year due to currency exchange and weak volumes.

Latest articles

Investors have been holding their breath for a Fed rate cut for a while now. But are they prepared in the event that that doesn't happen?

Innovative Industrial Properties (IIPR) continued to slump on July 22. The stock lost almost 6.8% of its value on the day.

22 Jul

Why AT&T Stock Is Down 2.2% Today

WRITTEN BY Ambrish Shah

AT&T stock (T) was trading at $32.14 with a 2.0% loss for the day. Earlier today, it posted a low of $32.08. Is the stock overvalued right now?

The Walt Disney Company’s (DIS) superhero film Avengers: Endgame has finally surpassed the record set by James Cameron’s Avatar.

22 Jul

Why Durect Corporation Is Soaring Today

WRITTEN BY Margaret Patrick

On July 22, Durect Corporation (DRRX) entered into a collaboration with HIV leader Gilead Sciences (GILD).

Pure Alpha, the flagship fund of Ray Dalio’s Bridgewater Associates, fell 4.9% in the first half, the Financial Times reported.